Literature DB >> 19049598

Lability of GABAA receptor function in human partial epilepsy: possible relationship to hypometabolism.

René Pumain1, Mounia Sid Ahmed, Irène Kurcewicz, Suzanne Trottier, Jacques Louvel, Baris Turak, Bertrand Devaux, Jacques Laschet.   

Abstract

The function of the gamma-aminobutyric acid type A receptor (GABA(A)R) is maintained by endogenous phosphorylation. We have shown that the corresponding kinase is the glycolytic enzyme glyceraldehyde-3-phosphate dehydrogenase (GAPDH), using the locally produced glycolytic ATP. In addition, using cerebral tissue obtained during curative surgery for epilepsy, we showed that both the endogenous phosphorylation and the GABA(A)R function are significantly reduced in the "epileptogenic" cerebral cortex when compared to "control" tissue. This dysfunction likely contributes to seizure generation and/or transition from the interictal to the ictal state. Glucose utilization is decreased in the epileptogenic cortex of patients with partial epilepsy in the interictal state, but the relationship to the disorder remains unclear. We propose that this hypometabolism is related to the deficiency in the endogenous phosphorylation of GABA(A)R and the resulting greater lability of GABAergic inhibition. Several lines of evidences indeed suggest that GABAergic inhibition is costly in terms of metabolic consumption. The deficiency of this glycolysis-dependent mechanism may thus link epileptogenicity to glucose hypometabolism. The antiepileptic effect of ketogenic diets may be mediated by the subsequent rise in the NADH/NAD(+) index, which favors GABA(A)R endogenous phosphorylation and should contribute to restoration of GABAergic inhibition in the epileptogenic zone.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19049598     DOI: 10.1111/j.1528-1167.2008.01845.x

Source DB:  PubMed          Journal:  Epilepsia        ISSN: 0013-9580            Impact factor:   5.864


  8 in total

1.  Evolution of lobar abnormalities of cerebral glucose metabolism in 41 children with drug-resistant epilepsy.

Authors:  Tuhina Govil-Dalela; Ajay Kumar; Michael E Behen; Harry T Chugani; Csaba Juhász
Journal:  Epilepsia       Date:  2018-05-22       Impact factor: 5.864

Review 2.  The effects of the ketogenic diet on behavior and cognition.

Authors:  Tove Hallböök; Sunggoan Ji; Stuart Maudsley; Bronwen Martin
Journal:  Epilepsy Res       Date:  2011-08-27       Impact factor: 3.045

3.  A novel variant in the 3' UTR of human SCN1A gene from a patient with Dravet syndrome decreases mRNA stability mediated by GAPDH's binding.

Authors:  Tao Zeng; Zhao-Fei Dong; Shu-Jing Liu; Rui-Ping Wan; Ling-Jia Tang; Ting Liu; Qi-Hua Zhao; Yi-Wu Shi; Yong-Hong Yi; Wei-Ping Liao; Yue-Sheng Long
Journal:  Hum Genet       Date:  2014-01-25       Impact factor: 4.132

Review 4.  Harnessing the power of metabolism for seizure prevention: focus on dietary treatments.

Authors:  Adam L Hartman; Carl E Stafstrom
Journal:  Epilepsy Behav       Date:  2012-10-27       Impact factor: 2.937

Review 5.  Hungry Neurons: Metabolic Insights on Seizure Dynamics.

Authors:  Paolo Bazzigaluppi; Azin Ebrahim Amini; Iliya Weisspapir; Bojana Stefanovic; Peter L Carlen
Journal:  Int J Mol Sci       Date:  2017-10-28       Impact factor: 5.923

6.  Sulforaphane Ameliorates Metabolic Changes Associated With Status Epilepticus in Immature Rats.

Authors:  Jan Daněk; Šárka Danačíková; David Kala; Jan Svoboda; Sonam Kapoor; Antonín Pošusta; Jaroslava Folbergrová; Kateřina Tauchmannová; Tomáš Mráček; Jakub Otáhal
Journal:  Front Cell Neurosci       Date:  2022-03-15       Impact factor: 5.505

7.  Glucose Deficiency Elevates Acid-Sensing Ion Channel 2a Expression and Increases Seizure Susceptibility in Temporal Lobe Epilepsy.

Authors:  Haitao Zhang; Guodong Gao; Yu Zhang; Yang Sun; Huanfa Li; Shan Dong; Wei Ma; Bei Liu; Weiwen Wang; Hao Wu; Hua Zhang
Journal:  Sci Rep       Date:  2017-07-19       Impact factor: 4.379

Review 8.  Bioenergetic Mechanisms of Seizure Control.

Authors:  Richard Kovács; Zoltan Gerevich; Alon Friedman; Jakub Otáhal; Ofer Prager; Siegrun Gabriel; Nikolaus Berndt
Journal:  Front Cell Neurosci       Date:  2018-10-08       Impact factor: 5.505

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.